Hughes Thomas E. 4
4 · MIRAGEN THERAPEUTICS, INC. · Filed Jan 5, 2018
Insider Transaction Report
Form 4
Hughes Thomas E.
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-03+3,426→ 3,426 totalExercise: $9.72Exp: 2028-01-02→ Common Stock (3,426 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in four equal quarterly installments beginning on January 1, 2018 through December 31, 2018, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant.